Have a personal or library account? Click to login
The use of biomarkers in detecting subclinical cardiotoxicity in doxorubicin-based treatment for paediatric patients with acute lymphoblastic leukaemia Cover

The use of biomarkers in detecting subclinical cardiotoxicity in doxorubicin-based treatment for paediatric patients with acute lymphoblastic leukaemia

Open Access
|Apr 2017

Authors

Letiția Elena Radu

letitia_radu@yahoo.com

Paediatric Haematology and Oncology, Fundeni Clinical Institute,, Bucharest, Romania

Andra Beldiman

Fundeni Clinical Institute,, Bucharest, Romania

Ioana Ghiorghiu

“Carol Davila” University of Medicine and Pharmacy, Fundeni Clinical Institute, Bucharest, Romania
V. Gomoiu Children’s Hospital,, Bucharest, Romania

Alina Oprescu

Institute for Cardiovascular Diseases and Transplantation, Tirgu Mures, Romania

Constantin Arion

“Carol Davila” University of Medicine and Pharmacy, Fundeni Clinical Institute,, Bucharest, Romania

Anca Coliță

“Carol Davila” University of Medicine and Pharmacy, Fundeni Clinical Institute,, Bucharest, Romania
DOI: https://doi.org/10.1515/rrlm-2017-0014 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 157 - 164
Submitted on: Jan 29, 2016
|
Accepted on: Apr 1, 2017
|
Published on: Apr 28, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Letiția Elena Radu, Andra Beldiman, Ioana Ghiorghiu, Alina Oprescu, Constantin Arion, Anca Coliță, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.